Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
If your ALT or AST levels change significantly, your prescribing provider should evaluate the context, considering whether you have baseline liver disease, how rapidly you are losing weight (rapid fat loss can temporarily increase liver enzyme release), and whether any concomitant medications could be contributing
Continuous monitoring of patient outcomes and post-marketing surveillance will help ensure that these therapies are used safely and effectively
The dysesthesia question One side effect unique to retatrutide deserves special attention
Author contributions TMA: Validation, Software, Writing review & editing, Formal Analysis, Writing original draft, Methodology, Data curation, Conceptualization, Investigation, Visualization
& Helmann, J
